Shopping Cart
Remove All
Your shopping cart is currently empty
L 888607 is an effective and selective CRTH2 agonist (Ki: 0.8 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $316 | 7-10 days | 7-10 days | |
| 1 mL x 10 mM (in DMSO) | $313 | 7-10 days | 7-10 days |
| Description | L 888607 is an effective and selective CRTH2 agonist (Ki: 0.8 nM). |
| Targets&IC50 | EP2 receptor:8748 nM (ki), IP receptor:14434 nM (ki), EP3 III receptor:1260 nM (ki), DP/DP1 receptor:2331 nM (ki), CRTH2/DP2 receptor:0.8 nM (ki), EP4 receptor:4634 nM (ki), FPR:10018 nM (ki), TP receptor:283 nM (ki) |
| Molecular Weight | 375.84 |
| Formula | C19H15ClFNO2S |
| Cas No. | 860033-06-3 |
| Relative Density. | 1.46 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 150 mg/mL (399.11 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (8.78 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.